Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis

Genitourin Med. 1996 Aug;72(4):269-71. doi: 10.1136/sti.72.4.269.

Authors

A Pozniak¹, M R Nelson

Affiliation

¹ Department of Genitourinary Medicine, Kings Health Care NHS Trust, London, UK.

No abstract available

Publication types

Review

MeSH terms

AIDS-Related Opportunistic Infections / prevention & control*
Anti-Bacterial Agents / adverse effects
Anti-Bacterial Agents / therapeutic use*
Antibiotic Prophylaxis / adverse effects*
Antibiotic Prophylaxis / economics
Azithromycin / therapeutic use
Clarithromycin / therapeutic use
Drug Resistance, Microbial
Humans
Mycobacterium avium-intracellulare Infection / diagnosis
Mycobacterium avium-intracellulare Infection / epidemiology
Mycobacterium avium-intracellulare Infection / prevention & control*
Rifabutin / adverse effects
Rifabutin / therapeutic use*
Survival Analysis
Treatment Outcome

Substances

Anti-Bacterial Agents
Rifabutin
Azithromycin
Clarithromycin